Susquehanna International Group, LLP Revolution Medicines, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 54,670 shares of RVMD stock, worth $2.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

54,670

Previous 37,764 44.77%

Holding current value

$2.37 Million

Previous $1.47 Million 69.08%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$36.92 - $47.94 $624,169 - $810,473	16,906 Added 44.77%	54,670 $2.48 Million
Q2 2024 Aug 15, 2024	SELL	$30.14 - $40.68 $1.05 Million - $1.42 Million	-34,873 Reduced 48.01%	37,764 $1.47 Million
Q1 2024 May 07, 2024	SELL	$26.56 - $33.55 $2.02 Million - $2.55 Million	-76,015 Reduced 51.14%	72,637 $2.34 Million
Q4 2023 Feb 14, 2024	SELL	$18.35 - $34.12 $1.72 Million - $3.2 Million	-93,820 Reduced 38.69%	148,652 $4.26 Million
Q3 2023 Nov 14, 2023	BUY	$25.17 - $35.05 $1.32 Million - $1.84 Million	52,552 Added 27.67%	242,472 $6.71 Million
Q2 2023 Aug 11, 2023	SELL	$20.28 - $27.0 $2.37 Million - $3.16 Million	-116,903 Reduced 38.1%	189,920 $5.08 Million
Q1 2023 May 16, 2023	BUY	$20.76 - $30.09 $5.2 Million - $7.54 Million	250,484 Added 444.6%	306,823 $6.65 Million
Q4 2022 Feb 14, 2023	SELL	$17.68 - $25.53 $1.03 Million - $1.49 Million	-58,259 Reduced 50.84%	56,339 $1.34 Million
Q3 2022 Nov 14, 2022	BUY	$17.46 - $26.0 $1.66 Million - $2.47 Million	94,959 Added 483.52%	114,598 $2.26 Million
Q2 2022 Aug 15, 2022	SELL	$14.54 - $27.17 $514,454 - $961,328	-35,382 Reduced 64.31%	19,639 $383,000
Q1 2022 May 16, 2022	SELL	$17.31 - $26.4 $369,308 - $563,244	-21,335 Reduced 27.94%	55,021 $1.4 Million
Q4 2021 Feb 14, 2022	BUY	$24.35 - $33.7 $95,208 - $131,767	3,910 Added 5.4%	76,356 $1.92 Million
Q3 2021 Nov 15, 2021	BUY	$23.95 - $33.41 $823,377 - $1.15 Million	34,379 Added 90.31%	72,446 $1.99 Million
Q2 2021 Aug 11, 2021	SELL	$29.0 - $47.44 $4.29 Million - $7.02 Million	-147,884 Reduced 79.53%	38,067 $1.21 Million
Q1 2021 May 17, 2021	BUY	$37.21 - $54.43 $6.37 Million - $9.32 Million	171,148 Added 1156.17%	185,951 $8.53 Million
Q4 2020 Feb 16, 2021	BUY	$30.19 - $45.49 $192,038 - $289,361	6,361 Added 75.35%	14,803 $586,000
Q3 2020 Nov 16, 2020	BUY	$22.61 - $34.8 $190,873 - $293,781	8,442 New	8,442 $294,000
Q2 2020 Aug 14, 2020	SELL	$19.65 - $39.34 $538,292 - $1.08 Million	-27,394 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$20.0 - $34.08 $547,880 - $933,587	27,394 New	27,394 $600,000

Others Institutions Holding RVMD

# of Institutions

266

Shares Held

161M

Call Options Held

260K

Put Options Held

620K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Revolution Medicines, Inc. Transaction History